SELECT TOP (1000) [Source] ,[Taxon] ,[LowValue] ,[HighValue] ,[LowPCile] ,[HighPCile] FROM [DB_A5D9F7_Lassesen].[dbo].[JasonH]

Deinococcota Details: NCBI 1297, gram-negative or unknown [phylum]

| Deinococcaeota| Deinococcaeota Oren et al. 2015| Deinococcota| Deinococcus-Thermus| Thermus/Deinococcus group

  1. Radiation resistance: Deinococcota bacteria, particularly species within the genus Deinococcus, are known for their remarkable resistance to ionizing radiation, UV radiation, desiccation, and other extreme environmental conditions. This resistance is due to their highly efficient DNA repair mechanisms, which enable them to survive exposure to high levels of radiation that would be lethal to most other organisms. While the radiation resistance of Deinococcota bacteria has important implications for their ecological roles and adaptation to extreme environments, it is not directly relevant to human health impacts.

  2. Biotechnological applications: Deinococcota bacteria, especially Deinococcus radiodurans, have attracted interest for their potential biotechnological applications. Their robustness and ability to withstand harsh conditions make them promising candidates for various biotechnological processes, such as bioremediation of radioactive or contaminated environments, production of biofuels and bioplastics, and synthesis of valuable biomolecules. While these applications are primarily focused on environmental or industrial processes rather than direct human health impacts, they highlight the diverse metabolic capabilities and potential practical uses of Deinococcota bacteria.

  3. Genomic stability: Deinococcota bacteria possess highly stable genomes, despite their exposure to DNA-damaging agents such as radiation. Understanding the mechanisms underlying genomic stability in Deinococcota bacteria has implications for genetic engineering, synthetic biology, and biomedicine. While these applications may have indirect benefits for human health, such as improved methods for gene editing and genetic engineering, they are not directly related to health impacts of Deinococcota bacteria on humans.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Deinococcota

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 2.12 10 93249 0 38604 6924.2 200 16163 0 16176 0 %ile 100 %ile
biomesight 58.59 0 40 10 110 0 413 82.8 40 168.7 0 140 0 %ile 90.7 %ile
thorne 100 16 254 0 241 105.5 77 69 43 167 0 %ile 100 %ile
thryve 19.13 0 10 1 183 0 13490 623.8 22 6564.6 8 60 0 %ile 95.8 %ile
ubiome 0.89 21 180 0 172 65.4 47 54.6 21 180 11.1 %ile 77.8 %ile

External Reference Ranges for Deinococcota

Deinococcota (NCBI 1297) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Thorne (20/80%ile) 51.5 133.82 0.0052 0.0134
Statistic by Lab Source for Deinococcota
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 62.696 %   0.009 %  0.018 % 1795.0 2863
BiomeSightRdp 62.5 %   0.061 %  0.139 % 20.0 32
bugspeak 100 %   0.02 %  % 1.0 1
CerbaLab 66.667 %   0.003 %  0.001 % 2.0 3
custom 1.695 %   0.002 %  % 1.0 59
es-xenogene 17.241 %   0.025 %  0.02 % 5.0 29
Medivere 100 %   2.723 %  3.437 % 7.0 7
SequentiaBiotech 36.111 %   0.996 %  0.899 % 13.0 36
Thorne 85.227 %   0.006 %  0.006 % 75.0 88
Thryve 18.655 %   0.052 %  0.595 % 258.0 1383
Tiny 100 %   0.001 %  % 1.0 1
uBiome 0.884 %   0.007 %  0.005 % 7.0 792

Symptoms Associated with Deinococcota From Citizen Science Studies

Click on Impact for information if high or low levels are causing the impact

MagnitudeImpactSymptom

To see medical conditions associated you may be logged in

And display level must be raised above public.


This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)